| 标题 |
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Alexa B. Kimball; Gregor B. E. Jemec; Christopher J. Sayed; Joslyn S. Kirby; Errol P. Prens; et al 出版日期:2024-05-22 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)